PRKAR1A and adrenal gland neoplasm: Overall, immunohistochemical analysis revealed higher expression of StAR in adrenal tumors with mutations in PRKACA, GNAS, and PRKAR1A than in wild-type tumors, which exhibited lower expression of StAR.